728×90 Advertisement Banner
Back to A–Z Conditions
Other
Pulmonology

Fibrosis

Fibrosis is a condition characterized by the thickening and scarring of connective tissue, most commonly affecting the lungs (pulmonary fibrosis) but can also occur in other organs such as the liver, heart, and skin. Over time, the scarred tissue replaces healthy tissue, impairing normal organ function.

Symptoms

Shortness of breath (especially during exertion), chronic dry cough, fatigue and weakness, unexplained weight loss, aching muscles and joints, clubbing (widening and rounding) of fingertips or toes, and in advanced cases, respiratory failure.

Treatments

Treatment depends on the affected organ and underlying cause. For pulmonary fibrosis, options include antifibrotic medications (pirfenidone, nintedanib), corticosteroids and immunosuppressants, oxygen therapy, pulmonary rehabilitation, and in severe cases lung transplantation. Lifestyle changes such as smoking cessation are also important.

Risk Factors

Long-term exposure to occupational/environmental hazards (silica, asbestos, coal dust), autoimmune diseases (rheumatoid arthritis, scleroderma), certain medications (chemotherapy drugs, antibiotics), radiation therapy, smoking, gastroesophageal reflux disease (GERD), and genetic predisposition.

Prevalence

Pulmonary fibrosis affects approximately 5 million people worldwide. In the United States, about 200,000 cases are diagnosed annually. Idiopathic pulmonary fibrosis (IPF), the most common form, affects roughly 1 in 200 adults over age 70.

Related Articles